keyword
https://read.qxmd.com/read/37597079/timing-is-everything-neoadjuvant-versus-adjuvant-immunotherapy-in-patients-with-resectable-metastatic-melanoma
#21
EDITORIAL
Ashley M Holder, Jennifer A Wargo, Merrick I Ross
No abstract text is available yet for this article.
August 19, 2023: Annals of Surgical Oncology
https://read.qxmd.com/read/37536776/the-role-of-the-neonatal-registered-dietitian-nutritionist-past-present-and-future
#22
REVIEW
Stephanie Merlino Barr, Rosa K Hand, Tanis R Fenton, Sharon Groh-Wargo
Neonatal registered dietitian nutritionists (RDNs) are critical members of the neonatal intensive care unit (NICU) team due to their unique skillset of growth assessment, nutrition evaluation, and implementation of nutrition best practices. There is a paucity of data on appropriate staffing of neonatal RDNs in NICUs to promote improved patient outcomes. Here, the authors describe current neonatal RDN staffing and responsibilities in the US NICUs.
September 2023: Clinics in Perinatology
https://read.qxmd.com/read/37509290/presence-of-circulating-tumor-cells-predates-imaging-detection-of-relapse-in-patients-with-stage-iii-melanoma
#23
JOURNAL ARTICLE
Anthony Lucci, Sridevi Addanki, Yi-Ju Chiang, Salyna Meas, Vanessa N Sarli, Joshua R Upshaw, Mayank Manchem, Sapna P Patel, Jennifer A Wargo, Jeffrey E Gershenwald, Merrick I Ross
Stage III melanoma includes nodal metastasis or in-transit disease. Five-year survival rates vary between 32% and 93%. The identification of high-risk patients is important for clinical decision making. We demonstrated previously that ≥1 circulating tumor cells (CTCs) at baseline was associated with recurrence. In this study, we investigated how frequently CTCs were identified prior to radiologically detected recurrence. Stage III patients ( n = 325) had imaging at baseline and q 3 months. Baseline and q 6-12 months blood draws (7...
July 15, 2023: Cancers
https://read.qxmd.com/read/37503252/inflammation-induced-by-tumor-associated-nerves-promotes-resistance-to-anti-pd-1-therapy-in-cancer-patients-and-is-targetable-by-il-6-blockade
#24
Moran Amit, Erez Baruch, Priyadahrshini Nagarajan, Frederico Gleber-Netto, Xiayu Rao, Tongxin Xie, Shamima Akhter, Adebayo Adewale, Shajedul Islam, Brandi Mattson, Renata Ferrarotto, Michael Wong, Michael Davies, Sonali Jindal, Sreyashi Basu, Catherine Harwood, Irene Leigh, Nadim Ajami, Andrew Futreal, Micah Castillo, Preethi Gunarante, Ryan Goepfert, Nikhil Khushalani, Jing Wang, Stephanie Watowich, George Calin, Michael Migden, Paola Vermeer, Nisha D'Silva, Dan Yaniv, Jared Burks, Javier Gomez, Patrick Dougherty, Kenneth Tsai, James Allison, Padmanee Sharma, Jennifer Wargo, Jeffrey Myers, Neil Gross
While the nervous system has reciprocal interactions with both cancer and the immune system, little is known about the potential role of tumor associated nerves (TANs) in modulating anti-tumoral immunity. Moreover, while peri-neural invasion is a well establish poor prognostic factor across cancer types, the mechanisms driving this clinical effect remain unknown. Here, we provide clinical and mechniastic association between TANs damage and resistance to anti-PD-1 therapy. Using electron microscopy, electrical conduction studies, and tumor samples of cutaneous squamous cell carcinoma (cSCC) patients, we showed that cancer cells can destroy myelin sheath and induce TANs degeneration...
July 18, 2023: Research Square
https://read.qxmd.com/read/37494019/psychedelics-as-therapeutics-potential-and-challenges
#25
EDITORIAL
Nora D Volkow, Joshua A Gordon, Eric M Wargo
No abstract text is available yet for this article.
October 1, 2023: JAMA Psychiatry
https://read.qxmd.com/read/37488949/anakinra-associated-systemic-amyloidosis
#26
JOURNAL ARTICLE
Sara Alehashemi, Surendra Dasari, Anvitha Metpally, Kat Uss, Leslie A Castelo-Soccio, Theo Heller, Peter Kellman, Marcus Y Chen, Mark Ahlman, Jeff Kim, Susannah Wargo, Douglas B Kuhns, Danielle Fink, Adriana de Jesus, Paul S Martin, Richard Chang, Jonathan Bolanos, Chyi-Chia Richard Lee, Samih H Nasr, Raphaela Goldbach-Mansky, Ellen McPhail
OBJECTIVE: To describe a 41-year-old woman with a history of Neonatal onset multisystem inflammatory disease (NOMID), on treatment with daily subcutaneous injections of 600 mg of recombinant IL1RA (Interleukin-1 receptor antagonist protein), anakinra, since the age of 28, who presented with golf-ball size nodules at the anakinra injection sites, early satiety, new onset nephrotic syndrome in the context of normal markers of systemic inflammation. METHODS: Clinical history and histologic evaluation of biopsies of skin, gastric mucosa, and kidney with Congo-Red staining and proteomic evaluation of microdissected Congo Red-positive amyloid deposits by liquid chromatography-tandem mass spectrometry...
July 24, 2023: Arthritis & Rheumatology
https://read.qxmd.com/read/37471407/evaluation-of-healing-progression-at-surgical-incision-sites-and-the-use-of-antiseptics-for-enhancing-post-operative-survival-in-subyearling-chinook-salmon-oncorhynchus-tshawytscha
#27
JOURNAL ARTICLE
April S Cameron, A Michelle Wargo Rub, Benjamin P Sandford
In an attempt to develop more effective surgical implantation methods for fish, surgical incisions typical of those made for implanting micro-acoustic transmitters into the peritoneal cavity were evaluated on a weekly basis for healing progression using a suite of metrics. Additionally, four chemicals were evaluated at concentrations commonly used in aquaculture for their ability to prevent surgical site infection and thus to promote incision healing and survival. Chemical treatments included hydrogen peroxide (25, 50, and 100 mg l-1), salt (10 and 30 ppt), Argentyne (1:1, Argentyne:water), and PolyAqua (1/2 tsp 36 l-1)...
2023: PloS One
https://read.qxmd.com/read/37468627/diverse-clonal-fates-emerge-upon-drug-treatment-of-homogeneous-cancer-cells
#28
JOURNAL ARTICLE
Yogesh Goyal, Gianna T Busch, Maalavika Pillai, Jingxin Li, Ryan H Boe, Emanuelle I Grody, Manoj Chelvanambi, Ian P Dardani, Benjamin Emert, Nicholas Bodkin, Jonas Braun, Dylan Fingerman, Amanpreet Kaur, Naveen Jain, Pavithran T Ravindran, Ian A Mellis, Karun Kiani, Gretchen M Alicea, Mitchell E Fane, Syeda Subia Ahmed, Haiyin Li, Yeqing Chen, Cedric Chai, Jessica Kaster, Russell G Witt, Rossana Lazcano, Davis R Ingram, Sarah B Johnson, Khalida Wani, Margaret C Dunagin, Alexander J Lazar, Ashani T Weeraratna, Jennifer A Wargo, Meenhard Herlyn, Arjun Raj
Even among genetically identical cancer cells, resistance to therapy frequently emerges from a small subset of those cells1-7 . Molecular differences in rare individual cells in the initial population enable certain cells to become resistant to therapy7-9 ; however, comparatively little is known about the variability in the resistance outcomes. Here we develop and apply FateMap, a framework that combines DNA barcoding with single-cell RNA sequencing, to reveal the fates of hundreds of thousands of clones exposed to anti-cancer therapies...
July 19, 2023: Nature
https://read.qxmd.com/read/37465976/young-onset-rectal-cancer-unique-tumoral-microbiome-and-correlation-with-response-to-neoadjuvant-therapy
#29
JOURNAL ARTICLE
Michael G White, Ashish Damania, Jumanah Alshenaifi, Pranoti Sahasrabhojane, Oliver Peacock, Jillian Losh, Matthew C Wong, Zuzana Lutter-Berkova, George J Chang, Andrew Futreal, Jennifer A Wargo, Nadim J Ajami, Scott Kopetz, Y Nancy You
OBJECTIVE: External exposures, the host, and the microbiome interact in oncology. We aimed to investigate tumoral microbiomes in young-onset rectal cancers (YORCs) for profiles potentially correlative with disease etiology and biology. BACKGROUND: YORC is rapidly increasing, with 1 in 4 new rectal cancer cases occurring under the age of 50 years. Its etiology is unknown. METHODS: YORC (<50 y old) or later-onset rectal cancer (LORC, ≥50 y old) patients underwent pretreatment biopsied of tumor and tumor-adjacent normal (TAN) tissue...
October 1, 2023: Annals of Surgery
https://read.qxmd.com/read/37451906/madcam-1-a-newly-identified-microbial-gut-check-for-t-cells
#30
JOURNAL ARTICLE
Manoj Chelvanambi, Jennifer A Wargo
The gut microbiome influences the response, resistance, and toxicity of cancer immunotherapy, but the underlying mechanisms remain unknown. Fidelle et al. identify intestinal MAdCAM-1 as a mechanistic target through which gut dysbiosis blunts antitumor immunity, with opportunities for putative therapeutic intervention.
July 12, 2023: Trends in Immunology
https://read.qxmd.com/read/37428011/time-for-bugs-the-immune-microenvironment-and-microbes-in-pre-cancer
#31
JOURNAL ARTICLE
Mikayla Borthwick Bowen, Beth A Helmink, Jennifer A Wargo, Melinda S Yates
Major advances in our understanding of the tumor immune microenvironment (TIME) in established cancer have been made, including the influence of host-intrinsic (host genomics) and -extrinsic factors (such as diet and the microbiome) on treatment response. Nonetheless, the immune and microbiome milieu across the spectrum of pre-cancerous tissue and early neoplasia is a growing area of interest. There are emerging data describing the contribution of the immune microenvironment and microbiota on benign and premalignant tissues, with opportunities to target these factors in cancer prevention and interception...
July 10, 2023: Cancer Prevention Research
https://read.qxmd.com/read/37420098/using-gut-microorganisms-to-treat-cancer
#32
JOURNAL ARTICLE
Y David Seo, Nadim Ajami, Jennifer A Wargo
No abstract text is available yet for this article.
July 7, 2023: Nature Medicine
https://read.qxmd.com/read/37414216/efficacy-of-immune-checkpoint-inhibitors-for-the-treatment-of-advanced-melanoma-in-patients-with-concomitant-chronic-lymphocytic-leukemia
#33
JOURNAL ARTICLE
S H Cass, J W D Tobin, Y D Seo, G Gener-Ricos, E Z Keung, E M Burton, M A Davies, J L McQuade, A J Lazar, R Mason, M Millward, S Sandhu, C Khoo, L Warburton, V Guerra, A Haydon, H Dearden, A M Menzies, M Carlino, J L Smith, P Mollee, M Burgess, S Mapp, C Keane, V Atkinson, S A Parikh, S N Markovic, W Ding, T G Call, P J Hampel, G V Long, J A Wargo, A Ferrajoli
BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized management of advanced melanoma (AM). However, data on ICI effectiveness have largely been restricted to clinical trials, thereby excluding patients with co-existing malignancies. Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia and is associated with increased risk of melanoma. CLL alters systemic immunity and can induce T-cell exhaustion, which may limit the efficacy of ICI in patients with CLL...
July 4, 2023: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://read.qxmd.com/read/37369628/risk-emotional-support-child-abuse-potential-and-parenting-during-the-first-year-of-the-covid-19-pandemic
#34
JOURNAL ARTICLE
Lucy McGoron, Christopher J Trentacosta, Julie Wargo Aikins, Marjorie Beeghly, Jessica R Beatty, Sarah E Domoff, Elizabeth K Towner, Steven J Ondersma
The COVID-19 pandemic and associated mitigation efforts created stress that threatened parent and child well-being. Conditions that increase stress within families heighten the likelihood of child abuse, but social support can mitigate the impact. This short-term investigation considered whether cumulative risk, COVID-19 specific risk, and emotional support (one aspect of social support), were associated with child abuse potential during the pandemic. Additionally, we investigated whether emotional support moderated the association between COVID-19 specific risk and child abuse potential, and associations between child abuse potential and emotionally positive and emotionally negative parenting...
June 27, 2023: Child Maltreatment
https://read.qxmd.com/read/37365438/gut-oncomicrobiome-signatures-goms-as-next-generation-biomarkers-for-cancer-immunotherapy
#35
REVIEW
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, Guido Kroemer, Jennifer A Wargo, Nicola Segata, Laurence Zitvogel
Oncogenesis is associated with intestinal dysbiosis, and stool shotgun metagenomic sequencing in individuals with this condition might constitute a non-invasive approach for the early diagnosis of several cancer types. The prognostic relevance of antibiotic intake and gut microbiota composition urged investigators to develop tools for the detection of intestinal dysbiosis to enable patient stratification and microbiota-centred clinical interventions. Moreover, since the advent of immune-checkpoint inhibitors (ICIs) in oncology, the identification of biomarkers for predicting their efficacy before starting treatment has been an unmet medical need...
September 2023: Nature Reviews. Clinical Oncology
https://read.qxmd.com/read/37357378/tryptophan-synthesizing-bacteria-enhance-colonic-motility
#36
JOURNAL ARTICLE
Theresa B Legan, Brigitte Lavoie, Emilia Norberg, Isabella C Ley, Stephanie Tack, Thomas A Tompkins, Matthew J Wargo, Gary M Mawe
BACKGROUND: An emerging strategy to treat symptoms of gastrointestinal (GI) dysmotility utilizes the administration of isolated bacteria. However, the underlying mechanisms of action of these bacterial agents are not well established. Here, we elucidate a novel approach to promote intestinal motility by exploiting the biochemical capability of specific bacteria to produce the serotonin (5-HT) precursor, tryptophan (Trp). METHODS: Mice were treated daily for 1 week by oral gavage of Bacillus (B...
June 25, 2023: Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society
https://read.qxmd.com/read/37264079/publisher-correction-targeting-pd-l2-rgmb-overcomes-microbiome-related-immunotherapy-resistance
#37
Joon Seok Park, Francesca S Gazzaniga, Meng Wu, Amalia K Luthens, Jacob Gillis, Wen Zheng, Martin W LaFleur, Sarah B Johnson, Golnaz Morad, Elizabeth M Park, Yifan Zhou, Stephanie S Watowich, Jennifer A Wargo, Gordon J Freeman, Dennis L Kasper, Arlene H Sharpe
No abstract text is available yet for this article.
June 1, 2023: Nature
https://read.qxmd.com/read/37196631/from-bugs-to-drugs-bacterial-3-iaa-enhances-efficacy-of-chemotherapy-in-pancreatic-cancer
#38
JOURNAL ARTICLE
Y David Seo, Jennifer A Wargo
Tintelnot et al.1 identified enrichment of indole-3-acetic acid (3-IAA), a tryptophan metabolite produced by gut microbiota, as a predictor of chemotherapy response in pancreatic adenocarcinoma. Recapitulated in mouse models, 3-IAA represents a novel potential therapeutic approach for chemotherapy sensitization.
May 16, 2023: Cell reports medicine
https://read.qxmd.com/read/37173062/an-equitable-community-engaged-translational-framework-for-science-in-human-lactation-and-infant-feeding-a-report-from-breastmilk-ecology-genesis-of-infant-nutrition-begin-working-group-5
#39
JOURNAL ARTICLE
Laurie Nommsen-Rivers, Maureen M Black, Parul Christian, Sharon Groh-Wargo, M Jane Heinig, Kiersten Israel-Ballard, Julie Obbagy, Aunchalee E L Palmquist, Alison Stuebe, Stephanie Merlino Barr, Gabriela V ProaƱo, Lisa Moloney, Alison Steiber, Daniel J Raiten
Human milk is the ideal source of nutrition for most infants, but significant gaps remain in our understanding of human milk biology. As part of addressing these gaps, the Breastmilk Ecology: Genesis of Infant Nutrition (BEGIN) Project Working Groups 1-4 interrogated the state of knowledge regarding the infant-human milk-lactating parent triad. However, to optimize the impact of newly generated knowledge across all stages of human milk research, the need remained for a translational research framework specific to the field...
April 2023: American Journal of Clinical Nutrition
https://read.qxmd.com/read/37138075/targeting-pd-l2-rgmb-overcomes-microbiome-related-immunotherapy-resistance
#40
JOURNAL ARTICLE
Joon Seok Park, Francesca S Gazzaniga, Meng Wu, Amalia K Luthens, Jacob Gillis, Wen Zheng, Martin W LaFleur, Sarah B Johnson, Golnaz Morad, Elizabeth M Park, Yifan Zhou, Stephanie S Watowich, Jennifer A Wargo, Gordon J Freeman, Dennis L Kasper, Arlene H Sharpe
The gut microbiota is a crucial regulator of anti-tumour immunity during immune checkpoint inhibitor therapy. Several bacteria that promote an anti-tumour response to immune checkpoint inhibitors have been identified in mice1-6 . Moreover, transplantation of faecal specimens from responders can improve the efficacy of anti-PD-1 therapy in patients with melanoma7,8 . However, the increased efficacy from faecal transplants is variable and how gut bacteria promote anti-tumour immunity remains unclear. Here we show that the gut microbiome downregulates PD-L2 expression and its binding partner repulsive guidance molecule b (RGMb) to promote anti-tumour immunity and identify bacterial species that mediate this effect...
May 3, 2023: Nature
keyword
keyword
165473
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.